Effect of Phaseolus vulgaris on E. coli induced peritonitis and bacteraemia in mice by Khadagwanshi, Dipika et al.
Khadagwanshi et al                                                                                          Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):310-314 
ISSN: 2250-1177                                                                                  [310]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.08.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Effect of Phaseolus vulgaris on E. coli induced peritonitis and bacteraemia in 
mice 
1*Dipika Khadagwanshi, 1Sonkia Trivedi, 2Preeti Patel, 3Megha Jha 
1Department of Microbiology, Govt. M.L.B. Girls PG College, Bhopal 
2Department of Microbiology, Pinnacle Biomedical Research Institute, Bhopal 
3Head, Department of Research, Pinnacle Biomedical Research Institute, Bhopal 
 
ABSTRACT 
Infectious or non-infectious peritonitis leads to systemic inflammation due to violation of the peritoneum which is often fatal.  Evidences suggest 
that common bean (Phaseolus vulgaris L.) is a source of nutrients and contains phenolic compounds having antioxidant activity and its 
consumption has been linked with improved health benefits. The aim of the present investigation was evaluate the in vitro antibacterial, 
antioxidant activity and protective potential of the methanolic extract of P. vulgaris in E. coli induced model of peritonitis in albino wistar rats. 
Rats were pre-treated with 200 mg/kg and 400 mg/kg/bwt dose for 3 days and fourth day with E. coli (1×108 CFU/ml) strain and consecutively 
3 days treatment. Mortality was monitored for 14 days. After the death of rats or completion of the experiment rats were sacr ifice and kidney 
were used for our protocol. Colonies were count and statically analysis was done. Results showed dose dependent antibacterial activity. Thus 
the methanolic extract of P. vulgaris exhibited significant protection against E. coli induced peritonitis in normal rats. It significantly reduced the 
viable cells of E. coli when inoculated in rats. Activity is attributed to flavonoids and phenolic compounds. The present study thus suggests that 
methanolic extract of P. vulgaris significantly reverses peritoneal infection by E. coli in rats. It can be suggest that this medicinal formulation will 
be used as herbal medicine with no side effects. The high content of phenolic compounds, antioxidant activity and antibacterial activity of P. 
vulgaris indicate that they may impart health benefits when consumed and should be regarded as a valuable source of antioxidants. Thus, 
consumption of P. vulgaris seed along with coats might be recommended to gaining better nutritive benefits. 
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INTRODUCTION 
Phaseolus vulgaris (Linn) belong to the family of Fabaceae are 
widely consumed throughout the world. They play a 
significant role in human nutrition, being an important 
source of plant proteins, minerals and certain vitamins and 
exhibit, for this reason, high nutritional value. In last years, 
bioactive effects, associated with the fibres, polyphenols, and 
other beans components related to human health have 
gained attention1,2. Beans contain substantial amount of 
phenolic acids and flavonoids, some cultivars (red, black, and 
blue-violet coloured beans) show also anthocyanins, such as 
delphinidin and cyanidin, that overall attribute them a very 
strong antioxidant and antiradical activities3. Polyphenols 
are essentially present in the seed coats and in minor 
amount in cotyledons. The beneficial effects of polyphenols 
on human health are expressed primarily through the 
reduction of the oxidative stress4. Some polyphenols are also 
able to exert antiapoptotic, antiaging, as well as 
anticarcinogenic activity, overall inhibiting the cell 
proliferation processes5,6.Epidemiological studies have 
shown a strong link between the consumption of legumes 
and prevention of cancer risk, as well as the reduction of 
diabetes and cardiovascular risk through a normalization of 
the blood lipid and glucose profile7. Wedick et al. (2012) 
demonstrated that, among flavonoids, higher intakes of 
anthocyanins could be significantly associated with a lower 
risk of type 2 diabetes (risk: 0.85)8. Peritonitis is a serious 
disease, due to the inflammatory response in the serous 
membrane lining the abdominal cavity and viscera. The 
immediate answers to peritonitis are hyperthermia, bowel 
distension, hyperaemia, accumulation of gases and liquids, 
hypovolemia and pain. At the same time, there are cardiac, 
respiratory, renal and metabolic responses. It is also high 
contribution of fibroblasts that produce fibrin, responsible 
for the formation of intra-abdominal adhesions9-12. Although 
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often the treatment of peritonitis include mechanical 
removal of contaminants through peritoneal washings with 
saline, antibiotics and abdominal integrity restoration 
associated with modern intensive and surgical care units, 
currently peritonitis still accounts for approximately 50% of 
deaths consequent to sepsis13-16. Given popular use of P. 
vulgaris in treating diseases and previous research 
demonstrating antibacterial and antioxidant activity. The 
objective of this study was to estimate the total phenolic 
content, flavonoid content, antioxidant activity, antibacterial 
and protective potential of the methanolic extract of P. 
vulgaris in E. coli induced model of peritonitis in albino 
wistar rats. 
MATERIALS AND METHODS 
Plant material 
The leaves of P. vulgaris were collected from Pinnacle 
Biomedical Research Institute (PBRI), Bhopal, (M.P). The 
sample was identified by senior Botanist, Professor and head 
department of Botany, Safia College of Arts and Science, peer 
gate Bhopal. A herbarium of plants was submitted to the 
specimen library of Safia College of Arts and Science, peer 
gate Bhopal and The specimen voucher no. of P. vulgaris is 
388/Bot/Saf. 
Chemicals and reagents 
All the chemicals used in this study were obtained from 
HiMedia Laboratories Pvt. Ltd. (Mumbai, India), Sigma-
Aldrich Chemical Co. (Milwaukee, WI, USA), SD Fine-Chem 
Chem. Ltd. (Mumbai, India) and SRL Pvt. Ltd. (Mumbai, 
India).All the chemicals used in this study were of analytical 
grade. 
Bacterial strain 
The test organisms Escherichia coli (MTCC 2075) were 
obtained from the stocks of the Pinnacle Biomedical 
Research Institute, Bharat Scout and Guide Campus, Shyamla 
hills, Bhopal, (M.P.).  
Extraction of plant material 
Cold maceration 
Leaves of P. vulgaris were collected, washed and rinsed 
properly. They were dried in shade and powdered 
mechanically. About 1kg of the powder leaves was extracted 
with methanol and allow to standing for 2-3 days. At the end 
of the third day extract was filtered using whatmann No. 1 
filter paper to remove all un-extractable matter, including 
cellular materials and other constitutions that are insoluble 
in the extraction solvent. The entire extract was 
concentrated to dryness using rotary flash evaporator under 
reduced pressure and stored in an air tight container free 
from any contamination until it was used. Finally the 
percentage yields were calculated of the dried extracts17.  
Qualitative analysis of phytochemicals 
The extracts prepared for the study were subjected to 
preliminary phytochemical screening by using different 
reagents for identifying the presence or absence of various 
phytoconstituents viz., carbohydrates, proteins, alkaloids, 
tannins, steroid, flavonoids, polyphenols and terpenoids in 
various extracts of apple. The above phytoconstituents were 
tested as per the standard method18. 
Quantification of secondary metabolites 
Quantitative analysis is an important tool for the 
determination of quantity of phytoconstituents present in 
extracts. For this TPC and TFC are determined. Methanolic 
extracts of P. vulgaris are subjected to estimate the presence 
of TPC and TFC by standard procedure. 
Total phenolic content estimation (TPC) 
The amount of total phenolic in extracts was determined 
with the Folin Ciocalteu reagent. Concentration of (10-
50μg/ml) of gallic acid was prepared in methanol. 
Concentration of 1mg/ml of plant extract were also prepared 
in methanol and 0.5ml of each sample were introduced in to 
test and mixed with 2 ml of a 10 fold dilute folin ciocalteu 
reagent and 4 ml of 7.5% sodium carbonate. The tubes were 
covered with parafilm and it was then incubated at room 
temperature for 30 min with intermittent shaking and the 
absorbance were taken at 765 nm against using methanol as 
blank. Total phenolic content was calculated by the standard 
regression curve of gallic acid and the results were expressed 
as gallic acid equivalent (mg/g) 19.  
Total flavonoid content estimation (TFC) 
Different concentration of rutin (10-50μg/ml) was prepared 
in methanol. Test sample of near about same polarity 
(1mg/ml) were prepared. An aliquot 0.5ml of diluted sample 
was mixed with 2 ml of distilled water and subsequently 
with 0.15 ml of a 5% NaNO2 solution. After 6 min, 0.15 ml of 
a 10% AlCl3 solution was added and allowed to stand for 
5min and then 2 ml of 4% NaOH solution was added to the 
mixture. The final volume was adjusted to 5ml with distilled 
water and allowed to stand for another 15 min. Absorbance 
was determined at 510 nm against water as blank. Total 
flavonoid content was calculated by the standard regression 
curve of rutin/ quercetin20. 
In vitro Antioxidant activity 
DPPH radical scavenging activity 
For DPPH assay, the method of Gulçin et al., 200621 was 
adopted. A solution of 0.1mM DPPH (4mg/100ml) in 
methanol was prepared and 1 ml of this solution was mixed 
with 1 ml of different concentrations of the different extracts. 
The reaction mixture was vortexed thoroughly and left in the 
dark at room temperature for 30 min. Ascorbic acid was used 
as reference standard while methanol was used as control. 
Reduction of the stable DPPH radical was used as a marker of 
antioxidant capacity of P. vulgaris extracts. The change in 
colour was measured at 517 nm wavelength using 
methanolic solution as a reference solution. This was related 
to the absorbance of the control without the plant extracts. 
The percentage inhibition of free radical DPPH was 
calculated from the following equation:  
% inhibition = [(absorbance of control - absorbance of 
sample)/absorbance of control] × 100%. All the tests were 
carried out in triplicates. Though the activity is expressed as 
50% inhibitory concentration (IC50), IC50 was calculated 
based on the percentage of DPPH radicals scavenged. The 
lower the IC50 value, the higher is the antioxidant activity. 
Reducing power assay 
A spectrophotometric method was used for the 
measurement of reducing power. For this 0.5 ml of each of 
the extracts was mixed with 0.5ml phosphate buffer (0.2 M, 
pH 6.6) and 0.5 ml of 1% potassium ferricyanide (10 mg/ml). 
The reaction mixture was incubated at 50 ºC for 20 min 
separately, and then rapidly cooled, mixed with 1.5 ml of 
10% trichloroacetic acid and centrifuged at 6500 rpm for 10 
min. An aliquot (0.5ml) of the supernatant was diluted with 
distilled water (0.5ml) and then ferric chloride (0.5ml, 0.1%) 
was added and allowed to stand for 10 min. the absorbance 
was read spectrophotometrically at 700 nm. Ascorbic acid 
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(AA) was used as standard for construction of calibration 
curve22.  
Reducing Power (%) = (As / Ac) × 100 
Here, Ac is the absorbance of control and (As) as is the 
absorbance of samples (extracts) or standards. 
Anti bacterial sensitivity assay 
Well diffusion method 
The agar well diffusion method technique (Bauer et al., 
1966) 23 was used to determine the antibacterial activity of 
the plant extracts. Inoculation was done on sterile nutrient 
agar media plate using 18 hours old culture. A sterile 5mm 
cork borer was used to punch holes after solidification of 
media. The wells formed were filled with different 
concentrations of the extract which were labeled 
accordingly; 25mg/ml, 50mg/ml, 75mg/ml, 100mg/ml. The 
plates were then left on the bench for 1 hour for adequate 
diffusion of the extracts and incubated at 37°C for 48 hours 
in upright condition. The Experiment was repeated triplets 
and the mean values were calculated. 
In vivo study 
Animals 
All ethical and handling guidelines were followed as set by 
Indian Legislation and approved by Institutional Animal 
Ethics Committee. All animals were procured and housed in 
animal house maintained under standard hygienic 
conditions. All animals were given standard diet (Golden 
Feed, New Delhi) and water regularly. Animal experiments 
were approved by Institutional Animal Ethics Committee 
(IAEC) of Pinnacle Biomedical Research Institute. Protocol 
approval reference no. PBRI/IAEC/PN-19013. 
Acute oral toxicity 
The acute toxic class method set out in guideline is a 
stepwise procedure with the use of 3 animals of a single sex 
per step. Depending on the mortality and/or the moribund 
status of the animals, on average 2-4 steps may be necessary 
to allow judgment on the acute toxicity of the test substance. 
The substance is administered orally to a group of 
experimental animals at one of the defined doses. The 
substance is tested using a stepwise procedure, each step 
using three animals of a single sex. Absence or presence of 
compound-related mortality of the animals dosed at one step 
will determine the next step, i.e.;  no further testing is 
needed, dosing of three additional animals, with the same 
dose and, dosing of three additional animals at the next 
higher or the next lower dose level. Three animals are used 
for each step. The dose level to be used as the starting dose is 
selected from one of four fixed levels, 5, 50, 300 and 2000 
mg/kg body weight24. 
Treatment 
Animals were housed in a group of five in separate cages 
under controlled conditions of temperature (22 ± 2°C). All 
animals were given standard diet (Golden feed, New Delhi) 
and water, ad libitum. The environment was also regulated at 
25 ± 1 0C with 12/12 h (light/dark) cycle.  Animals were 
further divided in four groups with six animals in each group.  
Group I: Normal control (Normal saline were administered 
by oral route) 
Group II: Vehicle treated with Escherichia coli treated 
group: Escherichia coli (1×108 CFU/ml) were dissolved in 
normal saline and were administrated by oral route at a dose 
of 10ml/kg body weight.  
Group III: Standard drug treated group: Ofloxicin was 
dissolved in normal saline and was administrated by oral 
route at a dose of 5mg/kg body weight 
Group IV: 200 mg/kg extract treated group: Extract was 
dissolved in normal saline and was administrated by oral 
route at a dose of 200mg/kg body weight. 
Group V: 400 mg/kg extract treated group: Extract were 
dissolved in normal saline and was administrated by oral 
route at a dose of 400mg/kg body weight.  
Preparation for bacterial inoculums 
In brief, E. coli strain (MTCC 2075) were grown on nutrient 
broth medium (3 g of beef extract, 5 g of peptone and 5 g of 
NaCl, pH 7, sterilized by autoclaving at 120°C for 30 min.) 
from a single colony and incubated at 37°C for 16-18 h at 
37oC to obtain stationary growth phase cultures. The 
bacteria were then centrifuged (200 rpm) for 10 min at 4°C 
and the pellets were resuspended in PBS to an OD of 0.1 at 
660 nm, with a spectrophotometer, corresponding to 108 
CFU/ml25. 
Systemic infection by E. coli 
To produce infection, the rats were induced by the intra-
peritoneal with suitable inoculums in a volume of 0.2 to 0.25 
ml. After infection, the rats were observed twice daily and 
animals exhibiting profound inanition or an inability to reach 
food and water were sacrificed. The experimental design 
involved administration of each of the three test agents by 
daily oral dosing for a period of 14 days. dosing regimens 
were started on days -7,-6, -5, -4, -3, -2, -1, 0, 1, 2, 3, 4, 5, 6, 7 
and relative to the day of challenge (day 0) with 1×108 CFU of 
E. coli/ ml. Before and after the challenged day animals were 
treated with 200 mg/kg body weight and 400mg/kg body 
weight P. vulgaris extract and 5mg/kg body weight Ofloxicin 
respectively. Survival was monitored for all experimental 
groups till 14 day. These conditions were in accordance with 
those of previously described method26, with slight 
modification. The pathological status of the rat was 
determined by visual examination of internal organs after 
their death or sacrifice at the completion of the experiment. 
All surviving rats were killed by cervical dislocation on 15 
day determination of the numbers of CFU of E. coli per gram 
from the kidney27,28. This determination was made by 
aseptically removing and weighing both kidneys, 
homogenizing kidneys in w/v ml of saline with a high speed 
Homogenizer (Remi RQ-124A) and Kidney burden was 
determined by culturing of homogenates in physiological 
saline followed by plating 0.1 ml aliquots onto Nutrient agar 
plates. The plates were incubated at 37°C, and the number of 
colonies was enumerated after 48 h of growth29. All animal 
care procedures were supervised and approved by the 
Institutional Animals Ethics Committee (IAEC) of PBRI, 
Bhopal. 
Bacterial clearance 
E. coli was determined in the different groups by sampling 
retro blood at various intervals after 16 hrs and up to 14 
days (at which time maximum mortality will be recorded). 
The sample was serially diluted and plated on Nutrient agar 
media. Incubate it at 24 hours at 37°C temperature. After 
incubation colony count was determine by colony counter 
method.  
Biostatical interpretation 
All data are presented in Mean ±SD. Data were analyzed by 
One Way ANOVA followed by Bonfeffoni’s test. P<0.05 was 
considered as level of significance (n=4). 
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RESULT AND DISCUSSION 
Phytochemical analysis of methanolic extract of P. Vulgaris 
showed the presence of carbohydrate, alkaloids, flavonoids, 
phenolics, tannin, saponins, triterpenoids Table 1. 
Quantitative phytochemical assay was performed by 
calculating total phenolic content (TPC) and total flavonoid 
content (TFC). The TPC was calculated with respect to gallic 
acid (standard) and TFC was then calculated with respect to 
rutin taken as standard. Results shown in Table 2 & Fig 1, 2. 
Antioxidant activity of the samples was calculated through 
DPPH assay and reducing power assay. % inhibition was 
calculated as an indicative of antioxidant potency. The higher 
the % inhibition the better the activity. Ascorbic acid was 
taken as standard in both the tests and the values were 
comparable with concentration ranging from 20µg/ml to 
100µg/ml. A dose dependent activity with respect to 
concentration was observed (Table 3). The reducing ability 
of the compound usually depends on the reductants, which 
have been exhibited antioxidative capacity by breaking the 
free radical chain, donating a hydrogen atom. Reducing 
power assay was calculated in extracts and the values 
indicated a better activity (Table 4). In the acute toxicity 
study, no signs of toxicity were found upto the dose of 2000 
mg/kg body weight. Hence 1/10th and 1/5th doses i.e. 200 
mg/kg and 400 mg/kg have been fixed as ED50 for present 
study (Table 5). The methanolic extract was also tested for 
in-vitro antibacterial test using well diffusion assay (Table 
6). In-vivo antibacterial activity was tested by inducing 
peritonitis through E. coli. The activity of the extract was 
calculated by measuring the CFU/ml of the microorganisms. 
The experiment was done in groups of 5 containing normal 
control, vehicle control, standard (5mg/kg), extract (200 
mg/kg) and extract (400mg/kg). The results obtained 
indicated a dose dependent antibacterial activity of the 
extracts; the extract given at a concentration of 400 mg/kg 
had better activity than the one administered at 200 mg/kg 
(Table 7).  
Table 1 Result of phytochemical screening of P. Vulgaris 
S. no. Test’s name Result 
1.  Borntrager’s test Negative 
2.  Legal’s test Negative 
3.  Keller killioni test Negative 
4.  Test of saponins Negative 
5.  Mayer’s test Negative 
6.  Hager’s test Positive 
7.  Wagner’s test Positive 
8.  Molish test Negative 
9.  Fehling test Negative 
10.  Benedict’s test Positive 
11.  Biuret’s test Negative 
12.  Million’s test Negative 
13.  Ninhydrin test Negative 
14.  Lead acetate test Positive 
15.  Alkaline reagent test Positive 
16.  Shinoda test Positive 
17.  Ferric chloride test Positive 
18.  Lead acetate test Positive 
19.  Dilute iodin test Positive 
20.  Gelatin test Positive 
21.  Solubility test Positive 
 
Table 2 Total phenolic and total flavonoid content of P. Vulgaris 
S. No. Plant Total Phenol (gallic acid) 
(mg/100mg) 
Total flavonoid (Rutin) 
(mg/100mg) 
1. P. Vulgaris 5.175±0.2101 3.0833±0.7216 
 
 
Fig. 1 Graph of estimation of total phenolic content 
 
Fig. 2 Graph of estimation of total flavonoid content 
 
Table 3 DPPH assay of ascorbic acid, methanolic extract 
S. N. 
Conc. 
(µg/ml) 
Ascorbic acid 
(% Inhibition) 
Methanolic 
Extract 
(% Inhibition) 
1. 20 48.22 44.63 
2. 40 54.98 46.44 
3. 60 61.39 47.11 
4. 80 69.40 50.60 
5. 100 74.38 52.28 
 
Table 4 Result of reducing power assay 
S. 
N. 
Concentration  
Ascorbic 
acid 
Methanolic 
Extract 
1. 20µg/ml 0.142 3.706 
2. 40 µg/ml 0.211 3.725 
3. 60 µg/ml 0.269 3.747 
4. 80 µg/ml 0.34 3.793 
5. 100 µg/ml 0.397 3.818 
Table 5 Acute oral toxicity of Extract 
S. No. Groups 
Observations/ 
Mortality 
1. 5 mg/kg Bodyweight 0/3 
2. 50 mg/kg Bodyweight 0/3 
3. 300 mg/kg Bodyweight 0/3 
4. 2000 mg/kg Bodyweight 0/3 
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Table 6 Antibacterial activity of extract by well diffusion 
assay 
Bacteria 
Zone of inhibition 
25µg/ml 
50 
µg/ml 
75 
µg/ml 
100 
µg/ml 
E. coli 12 mm 14 mm 16 mm 19 mm 
 
Table 7 E. coli induced peritonitis 
Groups CFU/ml 
Normal Control 0.004 
Vehical control 0.0944 
Standard (5 mg/kg bwt) 0.02 
Extract (200 mg/kg bwt) 0.0764 
Extract (400 mg/kg bwt) 0.0468 
 
CONCLUSION 
Peritonitis continues to be an important problem in the health 
care system. P. Vulgaris has received some attention for its 
beneficial effects against several diseases. Our research study 
showed that the use of P. Vulgaris could effectively reduce the 
severity of acute peritonitis in our E. coli model. Further 
studies need to be done to verify the effect of phenolic 
compound, explore the mechanisms and promote the clinical 
use. An accurate biomarker for the early identification 
of peritonitis would be of great diagnostic value. An early 
finding of the correct diagnosis of peritonitis and the 
subsequent effective initiation of an appropriate treatment 
may help to lower the complication rate and to improve the 
prognosis 
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